We’re joined by camp counselors Cynthia Muñoz, who lives with cerebral palsy spastic diplegia, and Brian Rathfelder, who ...
They shared a womb, love playing with blocks and, according to their mother, share that special twin bond. But there is one thing they don’t have in common. Deegan was diagnosed with cerebral palsy ...
A father broke down in tears in the High Court as he told how he and his wife are on their own as they attempt to care for their brain-injured son, who has complex needs. The father’s tears came as ...
A father broke down in tears in the High Court as he told how he and his wife are on their own as they attempt to care for their brain-injured son, who has complex needs. The father’s tears came as ...
World number one disabled golfer Kipp Popert says prize money is needed to encourage more amateur players to compete in adaptive sport. Sevenoaks-based Popert, 27, was diagnosed with a form of ...
WORLD CUP winner Adam Rigby has announced his international retirement – but will continue to be involved in the wheelchair game as a match official. Rigby was part of England’s squads as they ...
THE report with Weller, in 1962, of microcephaly in 14 of 17 infants with generalized cytomegalic inclusion disease established the association of this Central-nervous-system defect with intrauterine ...
Texas Lions Camp is a summer camping facility dedicated to serving children from the State of Texas with physical disabilities, Down Syndrome, Cancer, and Type 1 Diabetes. The camp is located on over ...
I first met Kayla Sechler when we covered her sister Kassidy’s battle with heart disease. Kayla has her own impressive story about how she approaches life. Kayla has cerebral palsy, yet she’s taking ...
Neurotech receives key approvals and clearances to start Phase I/II trial of NTI164 into spastic diplegia cerebral palsy Trial aims to determine efficacy and safety of NTI164 from baseline to 12 weeks ...
Clinical-stage biopharmaceutical development company Neurotech International (ASX: NTI) has received official approval to commence a trial of its unique NTI164 proprietary drug formulation on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results